ATE103291T1 - Spezifische liganden fuer oestrogen- und progestagen-steroidhomonrezeptoren, deren verwendung und synthesezwischenprodukte. - Google Patents

Spezifische liganden fuer oestrogen- und progestagen-steroidhomonrezeptoren, deren verwendung und synthesezwischenprodukte.

Info

Publication number
ATE103291T1
ATE103291T1 AT89402862T AT89402862T ATE103291T1 AT E103291 T1 ATE103291 T1 AT E103291T1 AT 89402862 T AT89402862 T AT 89402862T AT 89402862 T AT89402862 T AT 89402862T AT E103291 T1 ATE103291 T1 AT E103291T1
Authority
AT
Austria
Prior art keywords
progestagen
ligands
receptors
steroid
homon
Prior art date
Application number
AT89402862T
Other languages
English (en)
Inventor
Marc Zeicher
Jacques Quivy
Original Assignee
Wallone Region
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wallone Region filed Critical Wallone Region
Application granted granted Critical
Publication of ATE103291T1 publication Critical patent/ATE103291T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT89402862T 1988-10-19 1989-10-17 Spezifische liganden fuer oestrogen- und progestagen-steroidhomonrezeptoren, deren verwendung und synthesezwischenprodukte. ATE103291T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8813737A FR2637803B1 (fr) 1988-10-19 1988-10-19 Ligands specifiques de recepteurs d'hormones steroides estrogenes et progestagenes, application et produits intermediaires de synthese
EP89402862A EP0365421B1 (de) 1988-10-19 1989-10-17 Spezifische Liganden für Östrogen- und Progestagen-Steroidhomonrezeptoren, deren Verwendung und Synthesezwischenprodukte

Publications (1)

Publication Number Publication Date
ATE103291T1 true ATE103291T1 (de) 1994-04-15

Family

ID=9371153

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89402862T ATE103291T1 (de) 1988-10-19 1989-10-17 Spezifische liganden fuer oestrogen- und progestagen-steroidhomonrezeptoren, deren verwendung und synthesezwischenprodukte.

Country Status (7)

Country Link
US (1) US5002753A (de)
EP (1) EP0365421B1 (de)
JP (1) JP2779011B2 (de)
AT (1) ATE103291T1 (de)
CA (1) CA2000979C (de)
DE (1) DE68914087T2 (de)
FR (1) FR2637803B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613937B1 (fr) * 1987-04-17 1989-07-21 Ire Celltarg Sa Ligands specifiques de recepteurs d'hormones steroides utiles pour la therapie ciblee ou l'imagerie medicale notamment du cancer
CN1041829C (zh) * 1993-06-28 1999-01-27 中国人民军事医学科学院放射医学研究所 17α-乙炔雌三醇-3-环戊醚的制备方法
US5427766A (en) * 1993-11-15 1995-06-27 The Dow Chemical Company Radiolabeled steroids for use in radiochemical-guided surgery
US5922699A (en) 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
US8124749B2 (en) 2007-06-12 2012-02-28 Case Western Reserve University Targeted cell death

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7405626A (nl) * 1974-04-26 1975-10-28 Akzo Nv Nieuwe 11-gesubstitueerde steroiden van de oestraanreeks.
JPS6051808A (ja) * 1983-08-31 1985-03-23 Sumitomo Electric Ind Ltd 光フアイバユニツト入り架空地線の接続部
DE3337179A1 (de) * 1983-10-10 1985-05-23 Schering AG, 1000 Berlin und 4709 Bergkamen Estran- und androstan-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende praeparate
ATE37429T1 (de) * 1984-07-20 1988-10-15 Tol O Matic Inc Stellglied fuer drehbewegungen.
DE3427795A1 (de) * 1984-07-25 1986-02-06 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 17(alpha)-halogenvinyl-estran-derivate, ihre herstellung und verwendung in der medizin
FR2613937B1 (fr) * 1987-04-17 1989-07-21 Ire Celltarg Sa Ligands specifiques de recepteurs d'hormones steroides utiles pour la therapie ciblee ou l'imagerie medicale notamment du cancer

Also Published As

Publication number Publication date
DE68914087T2 (de) 1994-09-08
US5002753A (en) 1991-03-26
FR2637803B1 (fr) 1993-07-09
DE68914087D1 (de) 1994-04-28
EP0365421B1 (de) 1994-03-23
JP2779011B2 (ja) 1998-07-23
CA2000979C (fr) 2000-06-13
EP0365421A1 (de) 1990-04-25
JPH02174794A (ja) 1990-07-06
FR2637803A1 (fr) 1990-04-20
CA2000979A1 (fr) 1990-04-19

Similar Documents

Publication Publication Date Title
Miller et al. Oestradiol synthesis from C19 steroids by human breast cancers.
Fisher et al. Cancer of the breast: size of neoplasm and prognosis
DE69126816T2 (de) Metallkomplexe, die Addukte von Säure und Dioximliganden enthalten, zur Markierung von Proteinen und anderen Amin enthaltenden Verbindungen
DE3687736D1 (de) Monoklonale antikoerper gegen humanen brustkrebs, korrespondierende hybridome, deren herstellung und verwendung.
Hanson et al. Preparation and evaluation of 17α-[125I] iodovinyl-11β-methoxyestradiol as a highly selective radioligand for tissues containing estrogen receptors: concise communication
AU6198086A (en) Agents for use in tumour diagnosis, imaging, localization or treatment
NO950037D0 (no) Fotoaktivering av proteiner for konjugasjonsformat
ATE103291T1 (de) Spezifische liganden fuer oestrogen- und progestagen-steroidhomonrezeptoren, deren verwendung und synthesezwischenprodukte.
Suga et al. Studies on the development of rat enamel by means of histochemistry, microradiography and polarized light microscopy
ZIELINSKI et al. 16 α-[125I] Iodo-11 β Methoxy-17 β-Estradiol: A Radiochemical Probe for Estrogen-Sensitive Tissues
McLaughlin et al. Cytotoxicity of Receptor-Mediated 16α [125I] Iodo-estradiol in Cultured MCF-7 Human Breast Cancer Cells
FR2613937B1 (fr) Ligands specifiques de recepteurs d'hormones steroides utiles pour la therapie ciblee ou l'imagerie medicale notamment du cancer
ATE28752T1 (de) 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
Sykes et al. Direct labeling of monoclonal antibodies with technetium-99m by photoactivation
Grigsby FDG-PET/CT: new horizons in anal cancer
Middlebrooks et al. Acute inflammatory thyromegaly following checkpoint inhibition: A new imaging entity?
Schuler et al. Immuno-, radio-, and chemotherapeutic studies in head and neck cancer: Highlights of the ASCO Annual Meeting 2017
DE69109515D1 (de) Neue 17-spiro substituierte Steroide, Verfahren zu deren Herstellung und Zwischenprodukten davon, ihre Verwendung als Arzneimittel sowie pharmazeutische Präparate davon.
Adjogatse et al. 170 Long term outcomes of the FiGaRO trial: 18F-FDG-PET in Guided Dose-Painting with Intensity Modulated Radiotherapy in Oropharyngeal Tumours
DE69414129D1 (de) Biphenyl jodierte derivate und ihre verwendung als diagnostikum
Rosenblum et al. Rational planning of brain tumour therapy based on laboratory investigations: comparison of single-and multiple-dose BCNU schedules.
Ruiter et al. Comparison of the carcinogenicity of 131 I and 125 I in the thyroid gland of the rat
Sivak One toxicology activity: Wireless technology research, LL. Cs tumor promotion expert panel
Delclos et al. Can the fletcher gamma ray colpostat system be extrapolated to other systems?
Buist et al. The treponema pallidum haemagglutination test